The role of mammalian target of rapamycin inhibitors in the management of post-transplant malignancy
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The role of mammalian target of rapamycin inhibitors in the management of post-transplant malignancy
Authors
Keywords
-
Journal
CLINICAL TRANSPLANTATION
Volume 28, Issue 6, Pages 635-648
Publisher
Wiley
Online
2014-03-14
DOI
10.1111/ctr.12357
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- De novoCancer-Related Death in Australian Liver and Cardiothoracic Transplant Recipients
- (2013) R. Na et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Renal Function at Two Years in Liver Transplant Patients Receiving Everolimus: Results of a Randomized, Multicenter Study
- (2013) F. Saliba et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Ridaforolimus as a single agent in advanced endometrial cancer: results of a single-arm, phase 2 trial
- (2013) N Colombo et al. BRITISH JOURNAL OF CANCER
- Tumor biology and pre-transplant locoregional treatments determine outcomes in patients with T3 hepatocellular carcinoma undergoing liver transplantation
- (2013) Peter T. W. Kim et al. CLINICAL TRANSPLANTATION
- Combined targeting of AKT and mTOR using MK-2206 and RAD001 is synergistic in the treatment of cholangiocarcinoma
- (2013) Florian Ewald et al. INTERNATIONAL JOURNAL OF CANCER
- Two-Year Randomized Controlled Prospective Trial Converting Treatment of Stable Renal Transplant Recipients With Cutaneous Invasive Squamous Cell Carcinomas to Sirolimus
- (2013) Judith M. Hoogendijk-van den Akker et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized Trial of Everolimus-Facilitated Calcineurin Inhibitor Minimization Over 24 Months in Renal Transplantation
- (2013) Diane Cibrik et al. TRANSPLANTATION
- Randomized Controlled Trial of Sirolimus for Renal Transplant Recipients at High Risk for Nonmelanoma Skin Cancer
- (2012) S. B. Campbell et al. AMERICAN JOURNAL OF TRANSPLANTATION
- A Randomized, Controlled Study to Assess the Conversion From Calcineurin-Inhibitors to Everolimus After Liver Transplantation-PROTECT
- (2012) L. Fischer et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Everolimus With Reduced Tacrolimus Improves Renal Function inDe NovoLiver Transplant Recipients: A Randomized Controlled Trial
- (2012) P. De Simone et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Phase II study of everolimus in patients with locally advanced or metastatic transitional cell carcinoma of the urothelial tract: clinical activity, molecular response, and biomarkers
- (2012) E. Seront et al. ANNALS OF ONCOLOGY
- De novomalignancies in renal transplant recipients: experience at a single center with 1882 transplant patients over 39 yr
- (2012) Hendrik Apel et al. CLINICAL TRANSPLANTATION
- A multicenter phase II trial (SAKK 36/06) of single-agent everolimus (RAD001) in patients with relapsed or refractory mantle cell lymphoma
- (2012) C. Renner et al. HAEMATOLOGICA
- Randomized Phase III Placebo-Controlled Trial of Letrozole Plus Oral Temsirolimus As First-Line Endocrine Therapy in Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer
- (2012) Antonio C. Wolff et al. JOURNAL OF CLINICAL ONCOLOGY
- Early tacrolimus exposure after liver transplantation: Relationship with moderate/severe acute rejection and long-term outcome
- (2012) Manuel Rodríguez-Perálvarez et al. JOURNAL OF HEPATOLOGY
- Everolimus and Erlotinib as Second- or Third-Line Therapy in Patients with Advanced Non–Small-Cell Lung Cancer
- (2012) Vassiliki A. Papadimitrakopoulou et al. Journal of Thoracic Oncology
- Impact of sirolimus and tacrolimus on mortality and graft loss in liver transplant recipients with or without hepatitis C virus: An analysis of the Scientific Registry of Transplant Recipients Database
- (2012) Kymberly D. Watt et al. LIVER TRANSPLANTATION
- Combined targeting of AKT and mTOR synergistically inhibits proliferation of hepatocellular carcinoma cells
- (2012) Nicole Grabinski et al. Molecular Cancer
- Sirolimus and Secondary Skin-Cancer Prevention in Kidney Transplantation
- (2012) Sylvie Euvrard et al. NEW ENGLAND JOURNAL OF MEDICINE
- High toxicity of sorafenib for recurrent hepatocellular carcinoma after liver transplantation
- (2012) Katharina Staufer et al. TRANSPLANT INTERNATIONAL
- Early conversion to a sirolimus-based, calcineurin-inhibitor-free immunosuppression in the SMART trial: observational results at 24 and 36 months after transplantation
- (2012) Markus Guba et al. TRANSPLANT INTERNATIONAL
- Everolimus plus early tacrolimus minimization: a phase III, randomized, open-label, multicentre trial in renal transplantation
- (2012) Robert M Langer et al. TRANSPLANT INTERNATIONAL
- Sirolimus for the Treatment of Kaposi Sarcoma After Renal Transplantation: A Series of 10 Cases
- (2012) S. Yaich et al. TRANSPLANTATION PROCEEDINGS
- Conversion From Calcineurin Inhibitors to Everolimus With Low-Dose Cyclosporine in Renal Transplant Recipients With Squamous Cell Carcinoma of the Skin
- (2012) L. Caroti et al. TRANSPLANTATION PROCEEDINGS
- Comparative Analysis of Resection and Liver Transplantation for Intrahepatic and Hilar Cholangiocarcinoma
- (2011) Johnny C. Hong ARCHIVES OF SURGERY
- Phase 1/2 study of everolimus in advanced hepatocellular carcinoma
- (2011) Andrew X. Zhu et al. CANCER
- Two Drug Interaction Studies of Sirolimus in Combination with Sorafenib or Sunitinib in Patients with Advanced Malignancies
- (2011) T. C. Gangadhar et al. CLINICAL CANCER RESEARCH
- Spectrum of Cancer Risk Among US Solid Organ Transplant Recipients
- (2011) Eric A. Engels et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Phase II Study of Temsirolimus in Women With Recurrent or Metastatic Endometrial Cancer: A Trial of the NCIC Clinical Trials Group
- (2011) Amit M. Oza et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Study of the Mammalian Target of Rapamycin Inhibitor Ridaforolimus in Patients With Advanced Bone and Soft Tissue Sarcomas
- (2011) Sant P. Chawla et al. JOURNAL OF CLINICAL ONCOLOGY
- Predictive Index for Tumor Recurrence after Liver Transplantation for Locally Advanced Intrahepatic and Hilar Cholangiocarcinoma
- (2011) Johnny C. Hong et al. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
- Sirolimus-based immunosuppression in liver transplantation for hepatocellular carcinoma: A meta-analysis
- (2011) Wenhua Liang et al. LIVER TRANSPLANTATION
- Cyclosporine a mediates pathogenesis of aggressive cutaneous squamous cell carcinoma by augmenting epithelial-mesenchymal transition: Role of TGFβ signaling pathway
- (2011) Stephanie B. Walsh et al. MOLECULAR CARCINOGENESIS
- Everolimus for Advanced Pancreatic Neuroendocrine Tumors
- (2011) James C. Yao et al. NEW ENGLAND JOURNAL OF MEDICINE
- Everolimus in Postmenopausal Hormone-Receptor–Positive Advanced Breast Cancer
- (2011) José Baselga et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rapamycin Blocks Production of KSHV/HHV8: Insights into the Anti-Tumor Activity of an Immunosuppressant Drug
- (2011) Lisa A. Nichols et al. PLoS One
- Current Approaches to Skin Cancer Management in Organ Transplant Recipients
- (2011) Meena K. Singh et al. SEMINARS IN CUTANEOUS MEDICINE AND SURGERY
- Switch to a Sirolimus-Based Immunosuppression in Long-Term Renal Transplant Recipients: Reduced Rate of (Pre-)Malignancies and Nonmelanoma Skin Cancer in a Prospective, Randomized, Assessor-Blinded, Controlled Clinical Trial
- (2010) R. Salgo et al. AMERICAN JOURNAL OF TRANSPLANTATION
- A prospective randomised, open-labeled, trial comparing sirolimus-containing versus mTOR-inhibitor-free immunosuppression in patients undergoing liver transplantation for hepatocellular carcinoma
- (2010) Andreas A Schnitzbauer et al. BMC CANCER
- A phase I dose-escalation study to evaluate safety and tolerability of sorafenib combined with sirolimus in patients with advanced solid cancer
- (2010) I M E Desar et al. BRITISH JOURNAL OF CANCER
- A phase 2 study of the oral mammalian target of rapamycin inhibitor, everolimus, in patients with recurrent endometrial carcinoma
- (2010) Brian M. Slomovitz et al. CANCER
- Phase 3 trial of everolimus for metastatic renal cell carcinoma
- (2010) Robert J. Motzer et al. CANCER
- Phase II Trial of the Oral Mammalian Target of Rapamycin Inhibitor Everolimus in Relapsed or Refractory Waldenström Macroglobulinemia
- (2010) Irene M. Ghobrial et al. JOURNAL OF CLINICAL ONCOLOGY
- Temsirolimus Has Activity in Non–Mantle Cell Non-Hodgkin's Lymphoma Subtypes: The University of Chicago Phase II Consortium
- (2010) Sonali M. Smith et al. JOURNAL OF CLINICAL ONCOLOGY
- Multicenter Phase II Study of Everolimus in Patients With Previously Treated Metastatic Gastric Cancer
- (2010) Toshihiko Doi et al. JOURNAL OF CLINICAL ONCOLOGY
- Increased incidence of early de novo cancer in liver graft recipients treated with cyclosporine: An association with C2 monitoring and recipient age
- (2010) Angela S. W. Tjon et al. LIVER TRANSPLANTATION
- FDA Approval Summary: Temsirolimus as Treatment for Advanced Renal Cell Carcinoma
- (2010) V. E. Kwitkowski et al. ONCOLOGIST
- Results of the Conversion to Everolimus in Renal Transplant Recipients With Posttransplantation Malignancies
- (2010) C. Chiurchiu et al. TRANSPLANTATION PROCEEDINGS
- Phase III Study to Evaluate Temsirolimus Compared With Investigator's Choice Therapy for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma
- (2009) Georg Hess et al. JOURNAL OF CLINICAL ONCOLOGY
- Conversion From Calcineurin Inhibitors to Sirolimus Maintenance Therapy in Renal Allograft Recipients: 24-Month Efficacy and Safety Results From the CONVERT Trial
- (2009) Francesco P. Schena et al. TRANSPLANTATION
- Liver Transplantation for Hepatocellular Carcinoma Under Calcineurin Inhibitors
- (2008) Marco Vivarelli et al. ANNALS OF SURGERY
- Pivotal Role of mTOR Signaling in Hepatocellular Carcinoma
- (2008) Augusto Villanueva et al. GASTROENTEROLOGY
- Effects of the mTOR inhibitor sirolimus in patients with hepatocellular and cholangiocellular cancer
- (2008) Magnus Rizell et al. International Journal of Clinical Oncology
- Pharmacodynamic-Guided Modified Continuous Reassessment Method–Based, Dose-Finding Study of Rapamycin in Adult Patients With Solid Tumors
- (2008) Antonio Jimeno et al. JOURNAL OF CLINICAL ONCOLOGY
- Immunosuppressive therapy and post-transplant malignancy
- (2008) S. Domhan et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started